scholarly article | Q13442814 |
P50 | author | Michael Platten | Q38799497 |
Philipp Kickingereder | Q40394749 | ||
Martin Bendszus | Q40395521 | ||
Timothy F. Cloughesy | Q47159504 | ||
Olivier Chinot | Q56384070 | ||
Thomas Sandmann | Q57159817 | ||
Lauren E Abrey | Q114444382 | ||
P2093 | author name string | Roger Henriksson | |
Benjamin M Ellingson | |||
Wolfgang Wick | |||
Warren P Mason | |||
Alexander Radbruch | |||
Ryo Nishikawa | |||
Martha Nowosielski | |||
Frank Saran | |||
Josep Garcia | |||
Cedric Revil | |||
P2860 | cites work | Modes of resistance to anti-angiogenic therapy | Q24608005 |
Identification of noninvasive imaging surrogates for brain tumor gene-expression modules | Q24647449 | ||
MGMT gene silencing and benefit from temozolomide in glioblastoma | Q27824832 | ||
Molecular mechanisms and clinical applications of angiogenesis | Q29547314 | ||
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis | Q29619677 | ||
A randomized trial of bevacizumab for newly diagnosed glioblastoma | Q30410163 | ||
Radiogenomics and imaging phenotypes in glioblastoma: novel observations and correlation with molecular characteristics | Q30870628 | ||
Relationship between gene expression and enhancement in glioblastoma multiforme: exploratory DNA microarray analysis | Q33370030 | ||
Transdifferentiation of glioblastoma cells into vascular endothelial cells | Q34694093 | ||
Effects of anti-angiogenesis on glioblastoma growth and migration: model to clinical predictions. | Q34703888 | ||
Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial | Q37240846 | ||
Clonal evolution of glioblastoma under therapy. | Q39704836 | ||
Prognostic implication of progression pattern after anti-VEGF bevacizumab treatment for recurrent malignant gliomas | Q40886583 | ||
Evaluation of pseudoprogression rates and tumor progression patterns in a phase III trial of bevacizumab plus radiotherapy/temozolomide for newly diagnosed glioblastoma | Q41654243 | ||
Microarray analysis verifies two distinct phenotypes of glioblastomas resistant to antiangiogenic therapy | Q41809732 | ||
Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice | Q42041511 | ||
Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma | Q46796397 | ||
MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial | Q48342416 | ||
Spatial expression of VEGF-A in human glioma | Q48488963 | ||
Progression types after antiangiogenic therapy are related to outcome in recurrent glioblastoma. | Q55460997 | ||
Bevacizumab does not increase the risk of remote relapse in malignant glioma. | Q55463287 | ||
P433 | issue | 4 | |
P921 | main subject | glioblastoma | Q282142 |
P304 | page(s) | 557-566 | |
P577 | publication date | 2017-09-01 | |
P1433 | published in | Neuro-Oncology | Q15724471 |
P1476 | title | Radiologic progression of glioblastoma under therapy - an exploratory analysis of AVAglio | |
P478 | volume | 20 |
Q58768236 | Angiogenesis and radiological tumor growth in patients with glioblastoma |
Q55456668 | Early treatment response evaluation using FET PET compared to MRI in glioblastoma patients at first progression treated with bevacizumab plus lomustine. |
Q58568066 | Evaluating cellularity and structural connectivity on whole brain slides using a custom-made digital pathology pipeline |
Q58556522 | Glioblastoma endothelium drives bevacizumab-induced infiltrative growth via modulation of PLXDC1 |
Q57177114 | Imaging biomarkers guided anti-angiogenic therapy for malignant gliomas |
Q54973707 | Imaging in neuro-oncology. |
Q56333957 | The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space |
Q90583610 | Treatment of newly diagnosed glioblastoma in the elderly: a network meta-analysis |